Michael J. Fink

Michael J. Fink

Partner

mfink@gbpatent.com

Firm Practice Areas/Practice Groups

Litigation and Trial
Post-Grant Patent Group
Interference and Derivation
Client Counseling, Licensing and Technology Transfer
Portfolio Management and Due Diligence
Asian
Startup Group

Experience

Patent Attorney - Greenblum and Bernstein, P.L.C. - 1988-Present
U.S. Department of Justice, Trial Attorney - 1984-1988

Offices/Professional Activities

Author, Greenblum and Bernstein, P.L.C. Litigation Newsletter
Lectures on patent litigation, post grant and inter partes  review proceedings, and patent monetization
Speaker at international conferences

Notable

Lead counsel in numerous patent infringement litigatons before U.S. District Courts.
Argued numerous appeals to US Court of Appeals for the Federal Circuit.
Lead or backup counsel in numerous Post Grant and Iinterference proceedings before USPTO.
Experienced in multi-party litigations and joint defensce groups.
Conducted numerous patent licensing negotiations, opinions, FTO studys, and due diligence reports.

Professional Associations and Memberships

American Bar Association
American Intellectual Property Law Association
Federal Circuit Bar Association
Licensing Executives Society


PTAB Bar Association

Representative Publications

Fink, M., (2017).  “8399514Update:  IPRs Involving Biotech and Pharmaceutical Patents”, 13 Journal of Generic Medicines 137-143.

Bruce H Bernstein, Michael J Fink and P Branko Pejic (2011, 2012 and 2013 Editions).  Getting the Deal Through, Licensing in the United States.

Fink, M., (2012).  “Substantive Federal Circuit decisions concerning pharmaceutical companies.”  9(2) Journal of Generic Medicines 86-94.

Stoner, B., Hon., Fink. M., Bailey, N., (2009). “Re-examination Proceedings Post-KSR in the Generic Medicine Industry.”  7-1 Journal of Generic Medicines 92-101.

Greenblum, N., Fink, M., Roylance, S., Pejic, P.B., Myers- Payne, S.C., Braier, P., (2008).  “Generic Drugs in a Changing Intellectual Property Landscape.”  The Pharmaceutical Regulatory Process, Second Edition, pps. 143-180, Ira R. Berry and Robert P. Martin, eds., Informa Health Care

Fink, M., (2007).  “US Legal and Regulatory Update:  Preliminary Injunctions in Pharmaceutical Cases.”  4 Journal of Generic Medicines 213-21.

Education

Massachusetts Institute of Technology, B.S. in Chemical Engineering (1981)
Albany Law School of Union University, J.D. (1984)

Courts

U.S. Supreme Court
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of Virginia
U.S. District Court for the District of Columbia

Bar Admissions

1985, New York
1985, USPTO
1988, District of Columbia
1990, Virginia